Leishmania donovani: Identification of novel vaccine candidates using human reactive sera and cell lines

Experimental Parasitology

Volumn 109, Issue 3, 2005, Pages 163-170

  Arora, Sunil K ^a   Pal, Nirbhai S ^a   Mujtaba, S ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cDNA, complementary DNA; CL, cutaneous leishmaniasis; DNA, deoxyribonucleic acid; eIF 4A, eukaryotic initiation factor 4A; L. donovani, Leishmania donovani; Recombinant antigens; Th1 cytokines; VL, visceral leishmaniasis

Indexed keywords

ANTIGEN; CD4 ANTIGEN; COMPLEMENTARY DNA; EPITOPE; GAMMA INTERFERON; LEISHMANIA VACCINE; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA LIBRARY; DNA SCREENING; DRUG EFFICACY; DRUG SCREENING; EXPERIMENTAL MODEL; FEMALE; HAMSTER; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; LEISHMANIA DONOVANI; MALE; MOLECULAR CLONING; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; SERUM; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ANIMALIA; CRICETINAE; EUKARYOTA; LEISHMANIA DONOVANI; PROTOZOA;

EID: 13844281637     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2004.12.009     Document Type: Article

References (20)

1. S.K. Arora, and S. Sehgal Identification of major antigens of Leishmania donovani using kala azar sera Medical Microbiology and Immunology 178 1989 81 88
2. S.K. Arora, P.C. Melby, and S. Sehgal Lack of serological specificity of recombinant heat shock protein of Leishmania donovani Immunology and Cell Biology 73 1995 446 451
3. C. Bogdan, H. Moll, W. Solbach, and M. Rollinghoff Tumor necrosis factor alpha in combination with IFN-gamma, but not with IL-4, activates murine macrophages for elimination of Leishmania major amastigotes European Journal of Immunology 20 1990 1131 1135
4. E.M. Carvalho, R. Badaro, S.G. Reed, T.C. Jones, and W.D. Johnson Absence of interferon gamma and interleukin-2 production during active visceral leishmaniasis Journal of Clinical Investigation 76 1985 2066 2069
5. B.L. Herwaldt Leishmaniasis Lancet 354 1999 1191 1999
6. C.L. Karp, S.H. EL-Safi, T.A. Wyun, M.M.H. Satti, A.M. Satti, A.M. Kordofani, F.A. Hashmi, M. Hag-Ali, F.A. Neva, T.B. Nuttman, and D.L. Sacks In vivo cytokine profiles in patients with kala azar. Marked elevation of both IL-10 and IFNg Journal of Clinical Investigation 91 1993 1644 1648
7. K.H. Lin, and S.Y. Cheng An efficient method to purify active eukaryotic proteins from the inclusion bodies in Escherichia coli Biotechniques 11 1993 748 751
8. F. Manca, J. Habeshaw, and A. Dalgleish The naïve repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV Journal of Immunology 146 1991 1964 1971
9. P.C. Melby Experimental leishmaniasis in humans: review Reviews in Infectious Diseases 13 1991 1009 1017
10. P.C. Melby, J. Yang, W. Zhao, L.E. Perez, and J. Cheng Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis Infection and Immunity 69 2001 4719 4725
11. E. Mougneau, F. Altare, A.E. Wakil, S. Zheng, T. Coppola, Z.-E. Wang, R. Waldman, R.M. Locksley, and N. Glaichenhaus Expression cloning of a protective Leishmania antigen Science 268 1995 563 566
12. H.W. Murray, K.E. Squires, C.D. Miralles, M.Y. Stoeckelle, A.M. Granger, A. Grenelli-Pipperano, and C. Bogdan Acquired resistance and granuloma formation in experimental visceral leishmaniasis. differential T-cell and lymphokine roles in initial and established disease Journal of Immunology 148 1992 1858 1863
13. A.S. Mustafa, F. Oftung, A. Deggerdal, H.K. Gill, R.A. Young, and T. Godal Gene isolation with human T lymphocyte probes Journal of Immunology 141 1988 2729 2733
14. + T cells of naïve healthy uninfected individuals Journal of Parasitic Diseases 27 2003 47 52
15. M.R. Piuvezam, D.M. Russo, J.M Burns Jr., Y.A. Skeiky, K.H. Grabstein, and S.G. Reed Characterization of responses of normal human T cells to Trypanosoma cruzi antigens Journal of Immunology 150 1993 916 924
16. P. Probst, E. Stromberg, H.W. Ghalib, M. Mozel, R. Badaro, S.G. Reed, and J.R Webb Jr. Identification and characterization of T-cell-stimulating antigens from Leishmania by CD4 T cell expression cloning Journal of Immunology 166 2001 498 505
17. B. Sukumaran, P. Tewary, S. Saxena, and R. Madhubala Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani Vaccine 21 2003 1292 1299
18. P. Tewary, B. Sukumaran, S. Saxena, and R. Madhubala Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen Vaccine 22 2004 3053 3060
19. World Health Organization, 2000. Division of control of Tropical Diseases: Leishmaniasis control home page. Available from: 〈 www.who.int/health-topics/leishmaniasis.htm〉 (updated 2000)
20. WHO Expert Committee Report, 1984. Technical report series 701, p. 139